Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) — Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday, April 21, 2023, at 3:30 p.m. ET.

The fireside chat-style event is entitled Turn Up the Radio – Basics on Radiotherapeutics, Nuclear Medicine and Radioisotopes. It will cover the rapidly emerging radiopharmaceuticals market, current supply chain limitations, and what must be done to enable next-generation cancer diagnostics and therapeutics.

Dr. Lewin’s broad experience includes time as an academic physician and as president of two successful nuclear medicine businesses. He trained in Cardiology and Nuclear Medicine at Cedar Sinai Medical Center and has served as an officer of the American Society of Nuclear Cardiology, the Society of Nuclear Medicine Cardiovascular Council, the Intersocietal Accreditation Commission for Nuclear Medicine/PET, and the Certification Council for Cardiovascular Imaging.

Interested parties can request access to the event from their Truist Securities client services representative.

About Nusano, Inc.
Nusano is a privately held medical technology company committed to bringing stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market. Nusano’s proprietary ion source is smaller and more efficient than existing production methods. This results in significantly greater yields and allows for the simultaneous manufacturing of multiple radioisotopes. Nusano’s technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. The company’s state-of-the-art production facility opens Q1 2025 in West Valley City, Utah. For more, please visit www.nusano.com.

Contacts:

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

20 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

20 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago